YourLawyer.com 1-800-LAW-INFO (1-800-529-4636)

Parker Waichman Alonso LLP Headlines by Topic

Epilepsy Drugs

Advisory Panel Rejects 'Black Box' Warnings of Suicide Risk on Epilepsy Drugs

Jul 11, 2008 | Parker Waichman Alonso LLP
An expert advisory panel refused a Food & Drug Administration (FDA) proposal to place a “Black Box”—the agency’s...

Epilepsy Drugs Targeted for Black Box Suicide Warning

Jul 8, 2008 | Parker Waichman Alonso LLP
Federal regulators want the makers of epilepsy drugs to add a black box warning to their labels about their association with suicidal thoughts and...

Neurontin Should Have Had Depression Warning, Neurologist Says

Jun 20, 2008 | Parker Waichman Alonso LLP
A British neurologist says he advised the maker of Neurontin to include a warning on its label about its potential to cause depression and...

New Suicide Warning for Epilepsy Drugs

Jun 12, 2008 | Parker Waichman Alonso LLP
United States drug reviewers just announced that epilepsy drugs are associated with a higher risk of suicidal thoughts and behavior.  The...

Epilepsy Drugs to Get Suicide Warnings, FDA Confirms

Jun 6, 2008 | Parker Waichman Alonso LLP
US regulators are very close to finalizing new suicide warnings for 11 epilepsy drugs, The Wall Street Journal reported today.  This past...

Epilepsy Drugs May Get New Suicide Warnings, In Spite of Pressure From Big Pharma

Jun 4, 2008 | Parker Waichman Alonso LLP
Federal regulators are considering new suicide warnings for some epilepsy drugs, but the pharmaceutical companies that make the medications are...

Dilantin Linked to Osteoporosis

Apr 30, 2008 | Parker Waichman Alonso LLP
A recent study revealed that the popular epilepsy drug Dilantin might be placing young women who take it for a year or more at higher risk for...

Epilepsy Drug No Help Against Migraines

Feb 12, 2008 | Parker Waichman Alonso LLP
The epilepsy drug oxcarbazepine was strongly believed to have prevented migraine headaches; however, a new study suggests that this is not so. ...

Page 1/1

Defective Drugs
* Denotes required field.

Title

* First Name

* Last Name

* Email Address

* Phone Number

Cell Phone Number

Office Phone Number

Street Address

Apartment/Suite

City

State

Zip Code

Please provide the best method and times to contact you:

Date of birth of person injured
(mm-dd-yyyy):

Name of drug:

Date you started taking the drug (mm-yyyy):

Date you stopped taking the drug (mm-yyyy):

Please describe any side effects:

Other Info:

No Yes, I agree to the Parker Waichman Alonso LLP disclaimers.Click here to review all.

Yes, I would like to receive the Parker Waichman Alonso LLP monthly newsletter, InjuryAlert.

please do not fill out the field below.

Home | Defective Drugs | Medical Devices | Toxic Substances | Accidents | Product Liability | Malpractice | Diseases
Nursing Home Negligence | Food Poisoning | Other Topics | Contact
Statement of Clients' Rights | Site Map | ReNu with MoistureLoc | Vioxx | Mesothelioma | Permax | Dostinex | Composix Kugel Mesh X Large Patch
Ortho Evra | Fosamax | Personal Injury Lawyer | Fusarium Keratitis | Stevens Johnson Syndrome

© 2002-2008 YourLawyer.com. All Rights Reserved.

Please note that you are not considered a client until you have signed a retainer agreement and your case has been accepted by us.
Prior results do not guarantee or predict a similar outcome with respect to any future matter.
Attorney Advertising

Parker Waichman Personal Injury News